Substituted 6,7 Dihydro 5 H Benzo[7]Annulene Compounds And Their Derivatives, Processes For Their Preparation And Therapeutic Uses Thereof

Sanofi
Application Awaiting Examination App No 202317033960 Chemical

Patent information

IP India · live record
Application number
202317033960
Filing date
15 May 2023
Status
Application Awaiting Examination
Publication number
31/2024
Publication type
INA
Invention field
Chemical

Abstract

Disclosed herein are compounds of the formula (I), or pharmaceutically acceptable salts thereof wherein R1 and R2 represent a hydrogen atom or a deuterium atom; R3 represents a hydrogen atom, a -COOH group or a -OH group; R3' and R3" represent a hydrogen atom, a methyl group, a methoxy group, a chlorine atom, a fluorine atom, or a cyano group; R4 and R5 represent a hydrogen atom, a halogen atom, a -IMH2 group, a (C1- C3)alkyl group, a (C1-C3)alkoxy group, or a -OH group; or R4 and R5 together form an oxo group or R4 and R5 together form a =NOCH3 group or a (C3-C5)cycloalkyl group; R7 represents a hydrogen atom, a methyl group, a -OH group or a fluorine atom; R6 represents a phenyl group, a fused phenyl group, a bicyclic group comprising 5 to 12 carbon atoms, a heteroaryl group comprising 2 to 9 carbon atoms and comprising from 1 to 3 heteroatoms, a cycloalkyl group comprising 3 to 7 carbon atoms, a (C3-C6) cycloalkyl (C1-C3) alkyl group, a 3 to 8 membered-heterocycloalkyl group, a (C1-C6)alkyl group or a phenyl (C1- C2) alkyl group; X represents - CH2-, -O- or -S-; Y represents -CH=, - N= or -CR" =; R8 represents a (C1-C3) alkyl group, a halogen atom, a cyano group, or a (C1-C3) fluoroalkyl group; R9 represents a hydrogen atom or a fluorine atom; RIO and RIO'represent a hydrogen atom or a fluorine atom; Rll represents a hydrogen atom a (C1-C3)alkyl group or a cyclopropyl group; n is 0, 1 or 2, and m is 0 or 1. Further disclosed are process for preparing the same, pharmaceutical compositions comprising them as well as said compounds of formula (I) for use as an inhibitor and degrader of estrogen receptors, in particular in the treatment of ovulatory dysfunction, cancer, endometriosis, osteoporosis, benign prostatic hypertrophy or inflammation.

Applicants

1
France
SANOFI 46 avenue de la Grande Armée 75017 Paris

Inventors

13
France
BERNARDELLI, Patrickc/o Sanofi, Patent Department 54, rue la Boétie 75008 Paris
France
BIANCIOTTO, Marcc/o Sanofi, Patent Department 54, rue la Boétie 75008 Paris
France
CERTAL, Victorc/o Sanofi, Patent Department 54, rue la Boétie 75008 Paris
France
DA ROCHA, Alicec/o Sanofi, Patent Department 54, rue la Boétie 75008 Paris
France
DE BRUIN, Béatricec/o Sanofi, Patent Department 54, rue la Boétie 75008 Paris
France
EL AHMAD, Youssefc/o Sanofi, Patent Department 54, rue la Boétie 75008 Paris
France
HALLEY, Frankc/o Sanofi, Patent Department 54, rue la Boétie 75008 Paris
France
MOUGENOT, Patrickc/o Sanofi, Patent Department 54, rue la Boétie 75008 Paris
France
NICOLAI, Ericc/o Sanofi, Patent Department 54, rue la Boétie 75008 Paris
France
PERIERS, Anne-Mariec/o Sanofi, Patent Department 54, rue la Boétie 75008 Paris
France
PETIT, Frédéricc/o Sanofi, Patent Department 54, rue la Boétie 75008 Paris
France
SLOWINSKI, Franckc/o Sanofi, Patent Department 54, rue la Boétie 75008 Paris
France
TERRIER, Corinnec/o Sanofi, Patent Department 54, rue la Boétie 75008 Paris

Documents

Sign in to open
Application documents
1 202317033960.pdf 15 May 2023
2 202317033960-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [15-05-2023(online)].pdf 15 May 2023
3 202317033960-STATEMENT OF UNDERTAKING (FORM 3) [15-05-2023(online)].pdf 15 May 2023
4 202317033960-FORM 1 [15-05-2023(online)].pdf 15 May 2023
5 202317033960-DECLARATION OF INVENTORSHIP (FORM 5) [15-05-2023(online)].pdf 15 May 2023
6 202317033960-COMPLETE SPECIFICATION [15-05-2023(online)].pdf 15 May 2023
7 202317033960-Proof of Right [24-07-2023(online)].pdf 24 Jul 2023
8 202317033960-FORM-26 [24-07-2023(online)].pdf 24 Jul 2023
9 202317033960-FORM 18 [30-09-2024(online)].pdf 30 Sep 2024